Harvey Robert Klingensmith - 01 Apr 2025 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Role: Director
Signature: /s/ Mark Tattoli, Attorney-in-Fact
Issuer symbol: CLB
Transactions as of: 01 Apr 2025
Net transactions value: $0
Form type: 4
Filing time: 02 Apr 2025, 14:37:18 UTC
Previous filing: 02 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLB	Common Stock	Options Exercise	$0	+9,317	+29%	$0.000000	41,962	01 Apr 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLB	Restricted Shares	Award	$0	+8,069		$0.000000	8,069	01 Apr 2025	Common Stock	8,069	$0.000000	Direct	F1
transaction	CLB	Restricted Shares	Options Exercise	$0	-9,317	-100%	$0.000000	0	01 Apr 2025	Common Stock	9,317	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance.
F2	The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025.